InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| R848 VacciGrade™ | Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... | 2019 | Biomacromolecules. | Lynn GM. et al. | DOI: 10.1021/acs.biomac.8b01473 |
| Imiquimod VacciGrade™ (R837) | Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... | 2019 | Biomacromolecules. | Lynn GM. et al. | DOI: 10.1021/acs.biomac.8b01473 |
| R848 (Resiquimod) | Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... | 2019 | Biomacromolecules. | Lynn GM. et al. | DOI: 10.1021/acs.biomac.8b01473 |
| QUANTI-Blue™ | Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... | 2019 | Biomacromolecules. | Lynn GM. et al. | DOI: 10.1021/acs.biomac.8b01473 |
| Normocin® - Antimicrobial Reagent | Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and me... | 2019 | Biomacromolecules. | Lynn GM. et al. | DOI: 10.1021/acs.biomac.8b01473 |
| ASC-GFP Reporter Monocytes | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |
| Poly(I:C) (LMW) / LyoVec™ | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |
| MDP | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |
| ATP | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |
| MSU Crystals | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |
| Poly(dA:dT) | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |
| Bafilomycin A1 | The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by ... | 2019 | Mol Cell. | Mehto S. et al. | DOI: 10.1016/j.molcel.2018.11.018 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Human inflammatory response of endotoxin affected by particulate matter-bound... | 2019 | Environ Pollut. | Moretti S. et al. | DOI: 10.1016/j.envpol.2018.09.148 |
| Mouse TLR4 Reporter HEK293 Cells (NF-κB) | Intraperitoneal injection of 4-hydroxynonenal (4-HNE), a lipid peroxidation p... | 2019 | Free Radic Biol Med. | Wang Y. et al. | DOI: 10.1016/j.freeradbiomed.2018.11.037 |
| Human TLR5 Reporter HEK293 Cells (NF-κB) | Naturally-Derived PHA-L Protein Nanoparticle as a Radioprotector Through Acti... | 2019 | J Biomed Nanotechnol. | Long W. et al. | DOI: 10.1166/jbn.2019.2665 |
| CLI-095 | Nurr1: A vital participant in the TLR4-NF-κB signal pathway stimulated by α-s... | 2019 | Neuropharm | Shao Q.H. et al. | DOI: 10.1016/j.neuropharm.2018.04.008 |
| Mouse TLR1-9 Agonist kit | LACC1 Regulates TNF and IL-17 in Mouse Models of Arthritis and Inflammation. | 2019 | J Immunol. | Skon-Hegg C. et al. | DOI: 10.4049/jimmunol.1800636 |
| Poly(I:C) HMW | LACC1 Regulates TNF and IL-17 in Mouse Models of Arthritis and Inflammation. | 2019 | J Immunol. | Skon-Hegg C. et al. | DOI: 10.4049/jimmunol.1800636 |
| Poly(I:C) (HMW) VacciGrade™ | LACC1 Regulates TNF and IL-17 in Mouse Models of Arthritis and Inflammation. | 2019 | J Immunol. | Skon-Hegg C. et al. | DOI: 10.4049/jimmunol.1800636 |
| HKLM | LACC1 Regulates TNF and IL-17 in Mouse Models of Arthritis and Inflammation. | 2019 | J Immunol. | Skon-Hegg C. et al. | DOI: 10.4049/jimmunol.1800636 |